← United States · Coverage record
US · SEC FORM 4
Neuronetics, Inc.
STIM · Nasdaq · CIK 0001227636 · Healthcare · Medical Devices
INSIDER SIGNAL
1 buyers · 5 purchase transaction lines · $1.0M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 53.0
- 53.0
- 52.9
- 52.8
- 51.9
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -29.2%
- 3M
- +19.0%
- 6M
- +57.8%
- 12M
- -28.3%
Volatility & liquidity
- Volatility
- 112.9%
- Beta
- —
- Avg daily value
- USD 4.4M
Valuation
- Market cap
- USD 162.3M
- P/E
- —
Fundamentals
- Profit margin
- -26.1%
- ROE
- -174.3%
- Industry
- Medical Devices
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-05 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 7,067,347
- Previous report
- 6,209,774
- Avg daily volume
- 887,720
- Days to cover
- 8.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 14,000 | USD 3.16 | USD 44,240 | SEC filing ↗ |
| 2026-07-14 | Chernett Jorey | Purchase (P) | Common Stock | 35,000 | USD 1.78 | USD 62,300 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.17 | USD 117,000 | SEC filing ↗ |
| 2026-05-12 | Chernett Jorey | Purchase (P) | Common Stock | 475,000 | USD 1.34 | USD 636,500 | SEC filing ↗ |
| 2026-04-21 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.51 | USD 151,000 | SEC filing ↗ |
| 2026-04-20 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.58 | USD 158,000 | SEC filing ↗ |
| 2026-03-30 | Chernett Jorey | Purchase (P) | Common Stock | 385,442 | USD 1.25 | USD 481,802 | SEC filing ↗ |
| 2026-03-27 | Chernett Jorey | Purchase (P) | Common Stock | 500,000 | USD 1.35 | USD 675,000 | SEC filing ↗ |
| 2026-03-26 | Chernett Jorey | Purchase (P) | Common Stock | 25,000 | USD 1.44 | USD 36,000 | SEC filing ↗ |
| 2026-03-25 | Chernett Jorey | Purchase (P) | Common Stock | 125,000 | USD 1.40 | USD 175,000 | SEC filing ↗ |
| 2026-03-20 | Chernett Jorey | Purchase (P) | Common Stock | 169,472 | USD 1.41 | USD 238,956 | SEC filing ↗ |
| 2026-03-19 | Chernett Jorey | Purchase (P) | Common Stock | 450,000 | USD 1.33 | USD 598,500 | SEC filing ↗ |
| 2026-03-18 | Chernett Jorey | Purchase (P) | Common Stock | 607,400 | USD 1.35 | USD 819,990 | SEC filing ↗ |
| 2026-03-17 | Chernett Jorey | Purchase (P) | Common Stock | 531,000 | USD 1.16 | USD 615,960 | SEC filing ↗ |
| 2024-09-12 | CASCELLA ROBERT | Purchase (P) | Common Stock | 100,000 | USD 0.75 | USD 75,000 | SEC filing ↗ |
Form 4 evidence
52 transaction lines in the latest 365-day window; 318 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 14,000 | USD 3.16 | USD 44,240 | SEC filing ↗ |
| 2026-07-23 | Naor Nir | Award / grant (A) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-14 | Chernett Jorey | Purchase (P) | Common Stock | 35,000 | USD 1.78 | USD 62,300 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 14,000 | USD 3.16 | USD 44,240 | SEC filing ↗ |
| 2026-07-23 | Naor Nir | Award / grant (A) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-14 | Chernett Jorey | Purchase (P) | Common Stock | 35,000 | USD 1.78 | USD 62,300 | SEC filing ↗ |
| 2026-06-15 | MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LP | J (J) | Common Stock | 42,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-15 | Amin Avinash | J (J) | Common Stock | 42,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | MADRYN HEALTH ADVISORS GP II, LLC; MADRYN HEALTH ADVISORS II, LP; MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP; Madryn Asset Management, LP; Madryn Health Partners II, LP; Madryn Select Opportunities, LP | J (J) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | Rosengarten Megan | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | MUIR GLENN P | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | Cucuz Sasha | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | CONLEY SHERYL L | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | CASCELLA ROBERT | Award / grant (A) | Common Stock | 36,250 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-28 | Amin Avinash | Award / grant (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.17 | USD 117,000 | SEC filing ↗ |
| 2026-05-12 | Chernett Jorey | Purchase (P) | Common Stock | 475,000 | USD 1.34 | USD 636,500 | SEC filing ↗ |
| 2026-04-21 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.51 | USD 151,000 | SEC filing ↗ |
| 2026-04-20 | Chernett Jorey | Purchase (P) | Common Stock | 100,000 | USD 1.58 | USD 158,000 | SEC filing ↗ |
| 2026-03-30 | Chernett Jorey | Purchase (P) | Common Stock | 385,442 | USD 1.25 | USD 481,802 | SEC filing ↗ |
| 2026-03-27 | Chernett Jorey | Purchase (P) | Common Stock | 500,000 | USD 1.35 | USD 675,000 | SEC filing ↗ |
| 2026-03-26 | Chernett Jorey | Purchase (P) | Common Stock | 25,000 | USD 1.44 | USD 36,000 | SEC filing ↗ |
| 2026-03-25 | Chernett Jorey | Purchase (P) | Common Stock | 125,000 | USD 1.40 | USD 175,000 | SEC filing ↗ |
| 2026-03-23 | REUVERS DANIEL L. | Award / grant (A) | Common Stock | 1,500,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-20 | Chernett Jorey | Purchase (P) | Common Stock | 169,472 | USD 1.41 | USD 238,956 | SEC filing ↗ |
| 2026-03-19 | Sullivan Keith J | Sale (S) | Common Stock | 46,289 | USD 1.34 | USD 62,027 | SEC filing ↗ |
| 2026-03-19 | Pfanstiel Steven | Sale (S) | Common Stock | 16,431 | USD 1.34 | USD 22,018 | SEC filing ↗ |
| 2026-03-19 | MACAN WILLIAM ANDREW | Sale (S) | Common Stock | 16,005 | USD 1.34 | USD 21,447 | SEC filing ↗ |
| 2026-03-19 | Chernett Jorey | Purchase (P) | Common Stock | 450,000 | USD 1.33 | USD 598,500 | SEC filing ↗ |
| 2026-03-18 | Chernett Jorey | Purchase (P) | Common Stock | 607,400 | USD 1.35 | USD 819,990 | SEC filing ↗ |
| 2026-03-17 | Sullivan Keith J | Award / grant (A) | Common Stock | 112,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-17 | Pfanstiel Steven | Award / grant (A) | Common Stock | 25,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-17 | MACAN WILLIAM ANDREW | Award / grant (A) | Common Stock | 33,750 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | STIM |
| CIK | 0001227636 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 318 transaction lines from 2020-01-02 to 2026-08-14 72 P purchase lines · 120 S sale lines · 126 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.